Both α-hederin and thymoquinone have ACE as their predicted receptor in human system and therefore can be explored further for targeted therapies. The plant extract of N. sativa with the above-mentioned bioactive constituents is proposed to excel and outweigh any other treatment proposed so far for COVID-19 (Figure 5).